Parallel Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9K | Hold |
|
|||||
|
2025
Q1 | $61.3K | Sell |
|
|||||
|
2024
Q4 | $76.5K | Hold |
|
|||||
|
2024
Q3 | $87.9K | Hold |
|
|||||
|
2024
Q2 | $82.6K | Sell |
|
|||||
|
2024
Q1 | $140K | Buy |
|
|||||
|
2023
Q4 | $136K | Hold |
|
|||||
|
2023
Q3 | $126K | Buy |
|
|||||
|
2023
Q2 | $135K | Buy |
|
|||||
|
2023
Q1 | $138K | Buy |
|
|||||
|
2022
Q4 | $140K | Buy |
|
|||||
|
2022
Q3 | $134K | Hold |
|
|||||
|
2022
Q2 | $140K | Hold |
|
|||||
|
2022
Q1 | $162K | Hold |
|
|||||
|
2021
Q4 | $189K | Sell |
|
|||||
|
2021
Q3 | $230K | Hold |
|
|||||
|
2021
Q2 | $237K | Hold |
|
|||||
|
2021
Q1 | $218K | Buy |
|
|||||
|
2020
Q4 | $204K | Hold |
|
|||||
|
2020
Q3 | $181K | Hold |
|
|||||
|
2020
Q2 | $185K | Buy |
|
|||||
|
2020
Q1 | $121K | Hold |
|
|||||
|
2019
Q4 | $141K | Hold |
|
|||||
|
2019
Q3 | $122K | Hold |
|
|||||
|
2019
Q2 | $136K | Sell |
|
|||||
|
2019
Q1 | $160K | Hold |
|
|||||
|
2018
Q4 | $140K | Sell |
|
|||||
|
2018
Q3 | $236K | Buy |
|
|||||
|
2018
Q2 | $137K | Hold |
|
|||||
|
2018
Q1 | $141K | Hold |
|
|||||
|
2017
Q4 | $144K | Hold |
|
|||||
|
2017
Q3 | $141K | Buy |
|
|||||
|
2017
Q2 | $54K | Hold |
|
|||||
|
2017
Q1 | $51K | Hold |
|
|||||
|
2016
Q4 | $42K | Buy |
|